FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry. Pharmaceutical composition for treating obstructive airway diseases in the form of dry powder for inhalations with particle size of 64–70 nm contains budesonide, plant-origin phosphatidylcholine and maltose, with the following ratio of components, wt. %: budesonide 0.38–0.42; phosphatidylcholine 19–21, maltose 75.62–83.58.
EFFECT: treating obstructive airway diseases.
1 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF AN ALPHA1-PROTEINASE INHIBITOR (ALPHA1-ANTITRYPSIN) FOR PREVENTION AND/OR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND METHOD FOR PREVENTION AND/OR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME USING ALPHA1-ANTITRYPSIN | 2020 |
|
RU2757875C1 |
| BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
| LIPID DERIVATIVE OF SARCOLYSIN IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2017 |
|
RU2662086C1 |
| PHOSPHOLIPID NANOPARTICLE INDOMETACIN APPLICABLE IN OPHTHALMOLOGY | 2011 |
|
RU2456979C1 |
| PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
| PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
| COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
| INHALATION PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF BACTERIAL INFECTIOUS DISEASES | 2022 |
|
RU2777197C1 |
| COMPOSITIONS BASED ON CYCLODEXTRIN AND A BUDESONIDE DERIVATIVE AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2722414C2 |
| MEDICAL PRODUCT AND METHOD OF RHEUMATIC DISEASES TREATMENT | 2006 |
|
RU2330664C2 |
